China Resources Pharmaceutical Group Limited (HKG:3320)
4.850
-0.010 (-0.21%)
Jul 31, 2026, 4:08 PM HKT
HKG:3320 Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, HKG:3320 stock has a consensus rating of "Buy" and an average price target of $6.80. The average 1-year stock price forecast is 40.21% higher than the current stock price, while the lowest is $5.90 (+21.65%) and the highest is $7.52 (+55.05%).
Price Target: $6.80 (+40.21%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Apr 20, 2026.
Analyst Ratings
The average analyst rating for HKG:3320 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 6 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $6.82 | Buy | Maintains | $6.82 | +40.62% | Apr 20, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $7.00 | Buy | Maintains | $7.00 | +44.33% | Mar 27, 2026 |
Unknown Analyst Nomura No rating | Nomura | Buy Maintains $7.52 | Buy | Maintains | $7.52 | +55.05% | Mar 27, 2026 |
Unknown Analyst China Merchants Securities No rating | China Merchants Securities | Buy Maintains $6.30 | Buy | Maintains | $6.30 | +29.90% | Mar 26, 2026 |
Unknown Analyst Bank of America Securities No rating | Bank of America Securities | Buy Maintains $5.90 | Buy | Maintains | $5.90 | +21.65% | Mar 25, 2026 |
Financial Forecast
Revenue This Year
287.59B
from 269.57B
Increased by 6.68%
Revenue Next Year
302.36B
from 287.59B
Increased by 5.13%
EPS This Year
0.69
from 0.64
Increased by 8.51%
EPS Next Year
0.74
from 0.69
Increased by 7.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.